Surbhi Sidana, MD

Surbhi Sidana, MD, is an associate professor of medicine at Stanford University, where she is also leader of the Myeloma Disease Focused Group and associate director for clinical research in the Blood and Marrow Transplantation and Cellular Therapy Division.

Dr Sidana specializes in the treatment of multiple myeloma (MM) and related disorders. Her research focuses novel immunotherapies in MM and related disorders, including clinical trials, translational research, and epidemiologic and patient-reported outcome studies.

She is chair of the American Society of Hematology Committee on Communications. Dr Sidana also cochairs the International Myeloma Working Group Quality of Life Working Committee and co-leads a multi-institutional consortium on real-world outcomes with immunotherapies in MM.